Schwartz Biomedical

News


Categories

Latest News

Orthopaedic Company, BioPoly LLC, Announces Issuance of Patent

Posted: Feb 18th, 2010
FORT WAYNE, IN — BioPoly LLC, a local orthopaedic device manufacturer and Schwartz Biomedical subsidiary, announces that one of its key patents has issued. The issuance of this patent protects the BioPoly™ material claims and provides the company with a unique competitive advantage. This patent is one of an entire family of patents that have been filed to protect this technology. BioPoly LLC obtained an exclusive license for this technology from Colorado State University.

The BioPoly™ material is being used by the company in a host of orthopaedic implant applications. The unique characteristics of the BioPoly™ material allow it to interface optimally with orthopaedic tissues; thus, allowing direct contact between BioPoly™ and cartilage and/or bone. The first product being released to the market takes advantage of this attribute by the partial resurfacing of the knee joint; therefore, only the damaged portion of the knee surface is replaced, leaving the remaining healthy tissue intact.

According to the company’s Chief Financial Officer, Sabra Rowley CPA, “The issuance of this patent supports the investments made into this technology. We are excited to be able to offer the forthcoming implants to patients soon.”


About Schwartz Biomedical
Schwartz Biomedical is a tissue engineering company located in Fort Wayne, Indiana. With its engineers and scientists, the company innovates, researches, and develops novel tissue engineering and biologically based solutions to orthopaedic problems. Web site: www.schwartzbiomedical.com

About BioPoly
BioPoly LLC is an orthopaedic research, design and manufacturing company also located in Fort Wayne, Indiana. The company is developing and manufacturing products for use in the sports medicine, orthopaedics, and spinal markets.

BioPoly™ Raises $2M for Commercialization of Orthopaedic Products

Posted: Jan 12th, 2010
FORT WAYNE, IN — BioPoly LLC, a Schwartz Biomedical subsidiary, has raised more than $2M in its first round of equity financing. This capital will be used to complete product development and initiate launch of its first orthopaedic products into the market.

Although, this capital represents the first round of equity financing, initial support for this venture was provided by nearly $4M from two Indiana 21 Fund grants and other internal funding sources. The BioPoly™ team along with the collaborative efforts of Colorado State University and the Northeast Indiana Innovation Center has been developing a family of orthopaedic products. According to Dr. Herb Schwartz, President and CEO, “the unique patent-protected BioPoly™ technology allows us to apply very innovative solutions to orthopaedic problems.” One of the implant applications that is being developed includes using the BioPoly™ material as a synthetic cartilage for partial resurfacing of the knee. By partially resurfacing, the surgeon can replace the defective cartilage instead of the entire joint (total joint reconstruction) or even half of the joint (uni-knee), thus, allowing the patient to retain more of his/her native tissue.

Dr. Janine Campbell, Director of Science and Regulatory Affairs, stated that “the BioPoly™ material’s hydrophilic (water attracting) nature along with robust mechanical properties provides implants that optimally interface with orthopaedic tissues.” The combination of the hydrophilic characteristics and mechanical strength is accomplished via a proprietary method of incorporating two very dissimilar materials: a well-known orthopaedic polymer and a naturally occurring lubricating molecule known as a polysaccharide. The BioPoly™ material is essentially a self-lubricating orthopaedic plastic material that behaves much like the cartilage it is replacing.

In addition to partial resurfacing, the BioPoly™ team is also developing many other applications for use in orthopaedics, sports medicine, and spinal applications. “We and our investors are very excited to be able to introduce this technology to the orthopaedic industry,” said Schwartz. The first product is expected to launch very soon.


About Schwartz Biomedical:
Schwartz Biomedical is a tissue engineering company located in Fort Wayne, Indiana. With its engineers and scientists, the company innovates, researches, and develops novel tissue engineering and biologically based solutions to orthopaedic problems. Web site: www.schwartzbiomedical.com

About BioPoly:
BioPoly LLC is an orthopaedic research, design and manufacturing company also located in Fort Wayne, Indiana. The company is developing and manufacturing products for use in the sports medicine, orthopaedics, and spinal markets.

Schwartz Biomedical Sells BioDuct® Assets to Stryker Orthopaedics

Posted: Jul 15th, 2009
FORT WAYNE, IN —BioAvascular Solutions LLC (formerly known as BioDuct LLC), a Schwartz Biomedical subsidiary, announces the sale of BioDuct® assets to Stryker Howmedica Osteonics (Stryker Orthopaedics) of Mahwah, New Jersey. BioAvascular Solutions previously announced that it had received clearance from the FDA (Food and Drug Administration) on its BioDuct® meniscal device. According to Dr. Herb Schwartz, president of BioAvascular Solutions and Schwartz Biomedical, “We are very excited to have Stryker Orthopaedics launch this technology into the market. Stryker is an excellent strategic partner and will provide the enhanced distribution and marketing expertise for BioDuct® products. With their broad and experienced sales force and market presence, our confidence is high that the right surgeons will have access to this technology and patients can ultimately receive the benefit.”

The patented BioDuct® technology allows orthopaedic surgeons to repair the shock absorbing cartilage (meniscus) in the knee instead of removing it. Prior to the BioDuct® device, surgeons had no option but to excise the damaged portions of the meniscus, and this, unfortunately for the patient, can lead to (osteo)arthritis and even total knee replacement.

"The BioDuct® Meniscal Repair Device has the potential to be a landscape changer,” according to Frank Proch, Manager of Engineering for Schwartz Biomedical and BioAvascular Solutions. “It provides an elegant solution to one of the most common orthopaedic injuries and can significantly alter the algorithm surgeons use for meniscus injuries.”

As a result of this transaction, BioDuct LLC has changed its name to BioAvascular Solutions LLC and will retain the rights to certain applications of the technology.

About Schwartz Biomedical
Schwartz Biomedical, LLC, is an orthopaedic tissue engineering company located in the Northeast Indiana Innovation Center in Fort Wayne, Indiana. The company innovates and develops novel tissue engineering solutions for orthopaedic problems.
Web site: www.schwartzbiomedical.com

About Stryker Corporation
Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. Stryker works with respected medical professionals to help people lead more active and more satisfying lives. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; and endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment.
For more information about Stryker, please visit the company web site at www.stryker.com.

Source: Schwartz Biomedical, LLC 3201 Stellhorn Road Fort Wayne, IN 46815 Phone: 260-407-6468 Fax: 260-492-0452 Web: www.schwartzbiomedical.com Stryker Orthopaedics Contact: Aaron Kwittken Kwittken & Company t: (646) 747-7144 ddamoulakis@kwitco.com